Elite Pharmaceuticals (ELTP) Short Interest Ratio & Short Volume $0.58 +0.02 (+3.42%) As of 08/8/2025 03:57 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Elite Pharmaceuticals Short Interest DataElite Pharmaceuticals (ELTP) has a short interest of 2.45 million shares. This marks a -4.92% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 993,180 shares to cover all short positions.Current Short Interest2,449,800 sharesPrevious Short Interest2,576,700 sharesChange Vs. Previous Month-4.92%Dollar Volume Sold Short$1.30 millionShort Interest Ratio0.5 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares1,070,860,000 sharesPercentage of Shares Shorted0.23%Today's Trading Volume921,134 sharesAverage Trading Volume993,180 sharesToday's Volume Vs. Average93% Short Selling Elite Pharmaceuticals? Sign up to receive the latest short interest report for Elite Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartELTP Short Interest Over TimeELTP Days to Cover Over TimeELTP Percentage of Float Shorted Over Time Elite Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20252,449,800 shares $1.30 million -4.9%N/A0.5 $0.53 6/30/20252,576,700 shares $1.89 million +11.2%0.3%0.4 $0.73 6/15/20252,317,200 shares $1.56 million +1.0%0.3%0.6 $0.67 5/31/20252,293,300 shares $1.24 million +17.0%0.3%1.4 $0.54 5/15/20251,960,500 shares $885.36 thousand -1.4%0.2%1.4 $0.45 4/30/20251,987,600 shares $822.07 thousand -0.1%N/A2.2 $0.41 4/15/20251,988,500 shares $845.91 thousand +1.0%0.2%0.7 $0.43 3/31/20251,968,400 shares $856.25 thousand -0.8%0.2%1.6 $0.44 3/15/20251,984,000 shares $960.06 thousand +0.1%0.2%1.7 $0.48 2/28/20251,982,000 shares $970.98 thousand -5.8%0.2%1 $0.49 Get the Latest News and Ratings for ELTP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elite Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/20252,105,000 shares $1.12 million +3.6%0.2%0.8 $0.53 1/31/20252,031,600 shares $1.02 million +3.0%N/A1.3 $0.50 1/15/20251,972,500 shares $946.80 thousand -1.8%N/A0.6 $0.48 12/31/20242,008,300 shares $1.09 million -26.1%N/A0.8 $0.54 12/15/20242,717,700 shares $1.34 million +7.6%N/A0.9 $0.49 11/30/20242,526,500 shares $1.49 million +52.7%N/A0.5 $0.59 11/15/20241,654,500 shares $929.00 thousand +6.0%N/A0.4 $0.56 10/31/20241,560,500 shares $692.55 thousand -22.1%N/A0.1 $0.44 10/15/20242,004,100 shares $883.01 thousand -1.6%N/A0.6 $0.44 9/30/20242,036,000 shares $789.97 thousand -7.3%N/A0.6 $0.39 9/15/20242,195,500 shares $790.60 thousand +19.7%N/A0.2 $0.36 8/31/20241,834,800 shares $507.60 thousand +10.5%N/A0.3 $0.28 8/15/20241,661,100 shares $317.44 thousand +5.0%N/A1 $0.19 7/31/20241,581,500 shares $294.16 thousand -9.2%N/A1.4 $0.19 7/15/20241,740,800 shares $330.75 thousand +7.1%N/A1 $0.19 6/30/20241,625,700 shares $323.51 thousand +4.8%N/A1 $0.20 6/15/20241,550,800 shares $261.09 thousand -2.4%N/A2.4 $0.17 5/31/20241,588,700 shares $274.85 thousand +3.8%N/A1.3 $0.17 5/15/20241,530,700 shares $214.14 thousand -4.1%N/A1.3 $0.14 4/30/20241,595,900 shares $207.15 thousand -0.3%N/A1.8 $0.13 4/15/20241,601,300 shares $216.18 thousand +2.9%N/A1.4 $0.14 3/31/20241,555,700 shares $240.11 thousand -7.7%N/A1.4 $0.15 3/15/20241,684,700 shares $234.17 thousand +5.1%N/A0.9 $0.14 2/29/20241,602,900 shares $258.07 thousand +0.9%N/A0.4 $0.16 2/15/20241,588,800 shares $293.77 thousand +75.2%N/A0.5 $0.18 1/15/2024103,200 shares $18.01 thousand +24.8%N/A0 $0.17 12/31/202382,700 shares $11.58 thousand No ChangeN/A0 $0.14 11/30/202380,600 shares $11.08 thousand +58.4%N/A0 $0.14 11/15/202350,900 shares $7.38 thousand No ChangeN/A0 $0.15 10/15/2023228,000 shares $21.83 thousand +113.5%N/A0.3 $0.10Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again. 9/30/2023106,800 shares $10.02 thousand +862.2%N/A0.1 $0.09 9/15/202311,100 shares $865.80 -94.8%N/A0 $0.08 8/31/2023211,700 shares $18.63 thousand +1,283.7%N/A0 $0.09 8/15/202315,300 shares $711.45 -74.6%N/A0 $0.05 7/31/202360,300 shares $2.53 thousand +102.4%N/A0 $0.04 7/15/202329,800 shares $1.13 thousand No ChangeN/A0 $0.04 6/15/202311,000 shares $374.00 -7.6%N/A0 $0.03 5/31/202311,900 shares $367.71 +643.8%N/A0 $0.03 5/15/20231,600 shares $49.44 -85.7%N/A0 $0.03 4/30/202311,200 shares $369.60 +3,633.3%N/A0 $0.03 4/15/2023300 shares $9.30 -93.6%N/A0 $0.03 3/31/20234,700 shares $136.30 +193.8%N/A0 $0.03 3/15/20231,600 shares $50.40 -20.0%N/A0 $0.03 2/28/20232,000 shares $71.20 -95.5%N/A0 $0.04 2/15/202344,200 shares $1.70 thousand +44.9%N/A0.1 $0.04 1/31/202330,500 shares $1.03 thousand +74.3%N/A0 $0.03 1/15/202317,500 shares $525.00 +2,087.5%N/A0 $0.03 12/30/2022800 shares $23.60 +700.0%N/A0 $0.03 12/15/2022100 shares $3.00 -99.0%N/A0 $0.03 11/30/202210,000 shares $329.00 -54.3%N/A0 $0.03 11/15/202221,900 shares $755.55 +1,268.8%N/A0.1 $0.03 10/31/20221,600 shares $57.28 -96.3%N/A0 $0.04 10/15/202242,800 shares $1.33 thousand No ChangeN/A0 $0.03 9/15/2022400 shares $14.40 -99.4%N/A0 $0.04 8/31/202269,300 shares $2.48 thousand -2.8%N/A0 $0.04 8/15/202271,300 shares $3.21 thousand No ChangeN/A0.1 $0.05 7/15/20221,000 shares $42.90 -83.1%N/A0 $0.04 6/30/20225,900 shares $295.00 No ChangeN/A0 $0.05 5/31/20222,700 shares $123.39 No ChangeN/A0 $0.05 4/15/202216,900 shares $611.44 No ChangeN/A0 $0.04 2/28/2022212,900 shares $8.52 thousand +3,030.9%N/A0.2 $0.04 2/15/20226,800 shares $289.00 -89.5%N/A0 $0.04 1/31/202264,500 shares $2.55 thousand No ChangeN/A0.1 $0.04 12/31/2021100 shares $3.31 No ChangeN/A0 $0.03 12/15/2021100 shares $3.70 -99.6%N/A0 $0.04 11/30/202124,600 shares $883.14 +24,500.0%N/A0 $0.04 11/15/2021100 shares $3.82 -98.9%N/A0 $0.04 10/29/20219,400 shares $362.84 -38.2%N/A0 $0.04 10/15/202115,200 shares $608.00 +280.0%N/A0 $0.04 9/30/20214,000 shares $172.00 No ChangeN/A0 $0.04 8/31/202111,500 shares $543.95 +8.5%N/A0 $0.05 8/13/202110,600 shares $484.42 -46.7%N/A0 $0.05 7/30/202119,900 shares $953.21 +74.6%N/A0 $0.05 7/15/202111,400 shares $550.62 No ChangeN/A0 $0.05 6/15/202112,200 shares $668.56 No ChangeN/A0 $0.05 5/14/202121,600 shares $1.25 thousand +151.2%N/A0 $0.06 4/30/20218,600 shares $467.41 No ChangeN/A0 $0.05 3/31/20211,500 shares $87.00 -89.2%N/A0 $0.06 3/15/202113,900 shares $847.90 -65.6%N/A0 $0.06 2/26/202140,400 shares $2.59 thousand +1,054.3%N/A0 $0.06Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again. 2/12/20213,500 shares $261.80 +218.2%N/A0 $0.07 1/29/20211,100 shares $64.35 -83.3%N/A0 $0.06 12/31/202012,500 shares $675.00 No ChangeN/A0 $0.05 11/30/202027,400 shares $1.48 thousand -68.4%N/A0 $0.05 11/15/202086,700 shares $6.68 thousand No ChangeN/A0.1 $0.08 10/15/202012,100 shares $847.00 No ChangeN/A0 $0.07 8/31/202073,800 shares $5.83 thousand +939.4%N/A0 $0.08 8/14/20207,100 shares $477.83 -92.6%N/A0 $0.07 ELTP Short Interest - Frequently Asked Questions What is Elite Pharmaceuticals' current short interest? Short interest is the volume of Elite Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 2,449,800 shares of ELTP short. Learn More on Elite Pharmaceuticals' current short interest. Is Elite Pharmaceuticals' short interest increasing or decreasing? Elite Pharmaceuticals saw a decrease in short interest in the month of July. As of July 15th, there was short interest totaling 2,449,800 shares, a decrease of 4.9% from the previous total of 2,576,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Elite Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Elite Pharmaceuticals: Centessa Pharmaceuticals PLC Sponsored ADR (4.29%), Organon & Co. (5.68%), Arrowhead Pharmaceuticals, Inc. (8.99%), Recursion Pharmaceuticals, Inc. (34.95%), Agios Pharmaceuticals, Inc. (7.55%), Belite Bio, Inc. Sponsored ADR (0.55%), Galapagos NV (3.27%), Bausch Health Cos Inc. (2.56%), ImmunityBio, Inc. (8.14%), Denali Therapeutics Inc. (10.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Elite Pharmaceuticals stock? Short selling ELTP is an investing strategy that aims to generate trading profit from Elite Pharmaceuticals as its price is falling. ELTP shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Elite Pharmaceuticals? A short squeeze for Elite Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ELTP, which in turn drives the price of the stock up even further. How often is Elite Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELTP, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Centessa Pharmaceuticals Short Interest Organon & Co. Short Interest Arrowhead Pharmaceuticals Short Interest Recursion Pharmaceuticals Short Interest Agios Pharmaceuticals Short Interest Belite Bio Short Interest Galapagos Short Interest Bausch Health Cos Short Interest ImmunityBio Short Interest Denali Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ELTP) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elite Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elite Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELTP Stock Alerts